Immune System News and Research

RSS

CDC plans nationwide antibody study to determine the magnitude of the coronavirus pandemic

The U.S. Centers for Disease Control and Prevention (CDC) plans to launch a nationwide study to track how the novel coronavirus is spreading across the country.

20 May 2020

Prellis Externalized Human Immune System produces human antibodies against SARS-Cov2

Prellis Biologics, Inc. today announced that it has generated 300 human IgG antibodies that bind to either the S1 or S2 spike protein of the SARS-CoV2-Wuhan strain of the novel coronavirus.

20 May 2020

Researchers develop novel method to diagnose and monitor autoimmune disorders

Researchers from Prokhorov General Physics Institute of the Russian Academy of Sciences and the Moscow Institute of Physics and Technology have developed a novel method for diagnosing and monitoring autoimmune disorders.

19 May 2020

Does COVID-19 infect peripheral blood cells?

The emergence of the novel coronavirus outbreak in December 2019 was followed by its spread on a global scale unparalleled in the last 100 years. At present, it has claimed over 322,000 lives the world over, with over 4.88 million cases having tested positive.

19 May 2020

No SARS-COV-2 among young children in Belgium attending daycare, report researchers

A study conducted by researchers in Belgium has found no evidence to support concerns that asymptomatic young children may be a source of severe acute respiratory syndrome coronavirus disease 2 (SARS-CoV-2) transmission.

19 May 2020

Early life antibiotic exposure linked to increased risk of childhood obesity

Very young children exposed to antibiotics at an early age (from birth to 12 months) are associated with higher risks of childhood obesity and increased adiposity in early to mid-childhood.

19 May 2020

Phase IIB clinical trial initiated for treating hepatitis B-associated liver cancer

The first patients have been dosed in a multi-regional Phase IIB randomized, placebo-controlled clinical trial for the treatment of hepatitis B-associated liver cancer.

19 May 2020

X-ray experiments demonstrate a new way to block the entry of SARS-CoV-2

As scientists across the globe race to develop a vaccine against SARS-CoV-2, the coronavirus that causes COVID-19, an international team led by Davide Corti at Vir Biotechnology and David Veesler at the University of Washington has been working around the clock on a complementary approach - identifying neutralizing antibodies that could be used as a preventative treatment or as a post-exposure therapy.

19 May 2020

Study highlights need to focus on medications that address clot formation

Earlier this week, the BBC reported that one-third of COVID-19 patients developed dangerous blood clots.

19 May 2020

New capsules are critical for addressing the rapidly changing bacteria, says expert

Vaccines that protect people from infection by Streptococcus pneumonia, which kills up to 1 million children every year worldwide, train the immune system to recognize the pathogen's thick sugar capsule.

19 May 2020

Gene variants can increase risk of schizophrenia, shows study

Variants in a gene of the human immune system cause men and women to have different vulnerabilities to the autoimmune diseases lupus and Sjögren's syndrome, according to findings published in the journal Nature.

19 May 2020

Oxford Immunotec releases the T-SPOT® Discovery™ SARS-CoV-2 kit

Oxford Immunotec Global PLC, a global, high-growth diagnostics company, today announces the release of the T-SPOT Discovery SARS-CoV-2 test kit.

19 May 2020

Fibroblasts of different pancreatic diseases exhibit distinct properties, study reveals

Fibroblasts present in different pancreatic diseases are genetically distinct and their functions are 'programmed' by the unique environment of each disease, according to new research from the University of Liverpool (UK).

18 May 2020

Study aims to identify markers that predict how COVID-19 affects patients

COVID-19 is the UK's largest public health crisis since World War II. There is an urgent need to identify why some patients with the virus do very well whereas others need to be admitted to intensive care and may die from the disease.

18 May 2020

Roswell Park team proposes possible new strategy for treating pancreatic cancer

A possible new strategy for treating pancreatic cancer highlights the promise of collaboration between experts in both precision medicine and immunology.

18 May 2020

Boehringer Ingelheim acquires Northern Biologics to expand cancer immunology portfolio

Boehringer Ingelheim today announced the acquisition of Northern Biologics Inc., a wholly owned subsidiary of Northern LP. By acquiring this entity, which focuses on therapeutic antibodies targeting the tumor microenvironment, Boehringer Ingelheim is now positioned at the forefront of the stromal biology space - an emerging area in cancer immunology.

From Boehringer Ingelheim International GmbH 18 May 2020

Research explores how human enzymes could be used to exacerbate COVID-19

Centenary Institute researchers have examined the critical role of human enzymes and the coronavirus in a newly published scientific review article that explores potential strategies for COVID-19 disease treatment and management.

18 May 2020

New algorithm could help investigate the genetic clues behind immunity

Scientists with UC San Diego's Jacobs School of Engineering and the Qualcomm Institute have developed a new gene prediction algorithm, called MINING-D, that could help researchers investigate the genetic clues behind the variation of symptoms shown in COVID-19 patients - information that is key to creating a versatile and effective vaccine.

15 May 2020

Specific immune cells induced by vaccination are early indicators of vaccine efficacy

Ludwig-Maximilians-Universität in Munich researchers have shown that a specific class of immune cells in the blood induced by vaccination is an earlier indicator of vaccine efficacy than conventional tests for neutralizing antibodies.

15 May 2020

University of Greenwich develops compounds that can fight COVID-19 killer

Covid-19 treatment that could potentially also help protect cancer and organ transplant patients is being developed at the University of Greenwich.

15 May 2020

Immune System News and Research

CDC plans nationwide antibody study to determine the magnitude of the coronavirus pandemic

Prellis Externalized Human Immune System produces human antibodies against SARS-Cov2

Researchers develop novel method to diagnose and monitor autoimmune disorders

Does COVID-19 infect peripheral blood cells?

No SARS-COV-2 among young children in Belgium attending daycare, report researchers

Early life antibiotic exposure linked to increased risk of childhood obesity

Phase IIB clinical trial initiated for treating hepatitis B-associated liver cancer

X-ray experiments demonstrate a new way to block the entry of SARS-CoV-2

Study highlights need to focus on medications that address clot formation

New capsules are critical for addressing the rapidly changing bacteria, says expert

Gene variants can increase risk of schizophrenia, shows study

Oxford Immunotec releases the T-SPOT® Discovery™ SARS-CoV-2 kit

Fibroblasts of different pancreatic diseases exhibit distinct properties, study reveals

Study aims to identify markers that predict how COVID-19 affects patients

Roswell Park team proposes possible new strategy for treating pancreatic cancer

Boehringer Ingelheim acquires Northern Biologics to expand cancer immunology portfolio

Research explores how human enzymes could be used to exacerbate COVID-19

New algorithm could help investigate the genetic clues behind immunity

Specific immune cells induced by vaccination are early indicators of vaccine efficacy

University of Greenwich develops compounds that can fight COVID-19 killer

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News